Rubraquercus,

Thanks, very good read. I am highlighting part of your post below:

Quote:

---

If Covid-19 is a vascular disease, the best antiviral therapy might not be antiviral therapy.

An alternative theory is that the blood clotting and symptoms in other organs are caused by inflammation in the body due to an over-reactive immune response — the so-called cytokine storm. This inflammatory reaction can occur in other respiratory illnesses and severe cases of pneumonia, which is why the initial reports of blood clots, heart complications, and neurological symptoms didn’t sound the alarm bells. However, the magnitude of the problems seen with Covid-19 appear to go beyond the inflammation experienced in other respiratory infections.

---

So Remdesivir is not the answer. Leronlimab is. At least after the transition from a viral disease to an immune disease. However, with COVID being asymptomatic at the onset by the time patients realize they will be in the latter phase. Also during this (viral) RANTES is 3X to 5X already ...

We have the solution ....